trial

5HT3 Antagonism and Auditory Gating in Schizophrenia

NCTId NCT00018850

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

— · Completed

Enrollment —

Sponsored by US Department of Veterans Affairs

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Completed

Enrollment

—

Study type

Interventional

Allocation

Randomized

Model

Crossover

Masking

Double

Start

1998-06

Primary completion

—

Eligibility

ALL · 18 Years · 55 Years

Interventions & indications

Drugs

ondansetron neuropsychological testing nicotine Haloperidol

Indications

Schizophrenia Schizophrenia

Sites

1 total

Denver, United States

Facts & assertions

2 sourced

Phase

Status

COMPLETED

relationships

The graph out of here

drug

ondansetron

drug

neuropsychological testing

drug

nicotine

drug

Haloperidol

drug

lead_sponsor

US Department of Veterans Affairs

company

indication

Schizophrenia

indication

Schizophrenia

indication